Mode
Text Size
Log in / Sign up
N/A N=28 Randomized Treatment

Resiliency Programming for Caregivers of Children With Learning and Attentional Difficulties

Parenting · Stress · Learning Disabilities, Child · Attention Difficulties

Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Feasibility of Study Enrollment — 28 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SMART-3RP (Behavioral); Health Education Program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of Study Enrollment
28
PRIMARY
Feasibility of Intervention Attendance (% Attending at Least 6 of 8 Sessions)
11; 5
PRIMARY
Feasibility of Intervention Attendance (% Attending at Least 4 of 8 Sessions)
12; 9
PRIMARY
Feasibility of Follow-up Survey Completion
14; 11
PRIMARY
Acceptability of the Refined Intervention Content (SMART-3RP and HEP)
9; 5
PRIMARY
Acceptability of Number of Sessions
10; 9
PRIMARY
Acceptability of Teleconferencing Delivery
9; 8
PRIMARY
Acceptability- Group Cohesiveness
11; 11

Summary

This is a randomized open pilot trial enrolling up to 40 co-primary caregivers of children with LAD. Participants will be randomized to receive either mind-body resiliency group (SMART-LAD, intervention) or an evidence-based group intervention Health Education Program (HEP, control) which is a multiple behavior change program that addresses sleep, exercise, nutrition, substance use, and working with one's healthcare team. Both the SMART-3RP and HEP programs have been modified based on adaptions from our previous qualitative study.

Eligibility Criteria

Inclusion Criteria

  • English-speaking
  • Age 18 or older
  • Ability to participate in group, virtual sessions including access to computer, tablet, or smartphone, and internet
  • Parents or guardians of a child (< age 18) with LAD.

Exclusion Criteria

  • Parents with significant psychiatric conditions (i.e., active suicidality or psychosis) or who are otherwise unable to participate, at the investigators' clinical discretion.
  • Only one parent per family can participate.
  • Unwilling or unable to participate in the study
  • Considered medically or otherwise unable to participate by the study PI
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06492278). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search